Model-informed approaches to develop drug cost-saving dosing strategies for pembrolizumab.

Saved in:
Bibliographic Details
Title: Model-informed approaches to develop drug cost-saving dosing strategies for pembrolizumab.
Authors: Wang Y; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, the Netherlands., Bukkems LH; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, the Netherlands., van Hasselt JGC; Leiden Academic of Drug research, Leiden, the Netherlands., Crombag MR; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands., Dumoulin D; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Hendrikx JJMA; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Nuclear Medicine, Netherlands Cancer Institute, Amsterdam, the Netherlands., Theelen W; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., van der Hulle T; Department of Medical Oncology, Leiden University Medical Center, the Netherlands., Kapiteijn E; Department of Medical Oncology, Leiden University Medical Center, the Netherlands., Zwaveling J; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, the Netherlands., Becker A; Department of Pulmonology, Amsterdam University Medical Center, the Netherlands., Hiltermann J; Department of Pulmonology, University of Groningen, University Medical Center Groningen, the Netherlands., Hendriks LEL; Department of Pulmonary Diseases, GROW - Research Institute for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands., van Geel RMJM; Department of Clinical Pharmacy & Toxicology, NUTRIM Research Institute of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center+, Maastricht, the Netherlands., van Geffen WH; Department of Pulmonology, Radboudumc, Nijmegen, the Netherlands., van den Heuvel M; Department of Pulmonology, University Medical Center Utrecht, the Netherlands., Oude Munnink TH; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, the Netherlands., Smit EF; Department of Pulmonology, Leiden University Medical Center, the Netherlands., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, the Netherlands., Moes DJAR; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, the Netherlands. Electronic address: d.j.a.r.moes@lumc.nl., Ter Heine R; Department of Pharmacy, Pharmacology and Toxicology, Radboudumc, Nijmegen, the Netherlands.
Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2026 May 23; Vol. 243, pp. 116829. Date of Electronic Publication: 2026 May 23.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42258995
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Model-informed approaches to develop drug cost-saving dosing strategies for pembrolizumab.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Bukkems+LH%22">Bukkems LH</searchLink>; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Hasselt+JGC%22">van Hasselt JGC</searchLink>; Leiden Academic of Drug research, Leiden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Crombag+MR%22">Crombag MR</searchLink>; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Dumoulin+D%22">Dumoulin D</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Hendrikx+JJMA%22">Hendrikx JJMA</searchLink>; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Nuclear Medicine, Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Theelen+W%22">Theelen W</searchLink>; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Hulle+T%22">van der Hulle T</searchLink>; Department of Medical Oncology, Leiden University Medical Center, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Kapiteijn+E%22">Kapiteijn E</searchLink>; Department of Medical Oncology, Leiden University Medical Center, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Zwaveling+J%22">Zwaveling J</searchLink>; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Becker+A%22">Becker A</searchLink>; Department of Pulmonology, Amsterdam University Medical Center, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Hiltermann+J%22">Hiltermann J</searchLink>; Department of Pulmonology, University of Groningen, University Medical Center Groningen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Hendriks+LEL%22">Hendriks LEL</searchLink>; Department of Pulmonary Diseases, GROW - Research Institute for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Geel+RMJM%22">van Geel RMJM</searchLink>; Department of Clinical Pharmacy & Toxicology, NUTRIM Research Institute of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center+, Maastricht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Geffen+WH%22">van Geffen WH</searchLink>; Department of Pulmonology, Radboudumc, Nijmegen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+den+Heuvel+M%22">van den Heuvel M</searchLink>; Department of Pulmonology, University Medical Center Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Oude+Munnink+TH%22">Oude Munnink TH</searchLink>; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Smit+EF%22">Smit EF</searchLink>; Department of Pulmonology, Leiden University Medical Center, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Guchelaar+HJ%22">Guchelaar HJ</searchLink>; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Moes+DJAR%22">Moes DJAR</searchLink>; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, the Netherlands. Electronic address: d.j.a.r.moes@lumc.nl.<br /><searchLink fieldCode="AU" term="%22Ter+Heine+R%22">Ter Heine R</searchLink>; Department of Pharmacy, Pharmacology and Toxicology, Radboudumc, Nijmegen, the Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229005373%22">European journal of cancer (Oxford, England : 1990)</searchLink> [Eur J Cancer] 2026 May 23; Vol. 243, pp. 116829. <i>Date of Electronic Publication: </i>2026 May 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ltd%22">Elsevier Science Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9005373 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0852 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209598049%22">09598049 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42258995
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ejca.2026.116829
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 116829
    Titles:
      – TitleFull: Model-informed approaches to develop drug cost-saving dosing strategies for pembrolizumab.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wang Y
      – PersonEntity:
          Name:
            NameFull: Bukkems LH
      – PersonEntity:
          Name:
            NameFull: van Hasselt JGC
      – PersonEntity:
          Name:
            NameFull: Crombag MR
      – PersonEntity:
          Name:
            NameFull: Dumoulin D
      – PersonEntity:
          Name:
            NameFull: Hendrikx JJMA
      – PersonEntity:
          Name:
            NameFull: Theelen W
      – PersonEntity:
          Name:
            NameFull: van der Hulle T
      – PersonEntity:
          Name:
            NameFull: Kapiteijn E
      – PersonEntity:
          Name:
            NameFull: Zwaveling J
      – PersonEntity:
          Name:
            NameFull: Becker A
      – PersonEntity:
          Name:
            NameFull: Hiltermann J
      – PersonEntity:
          Name:
            NameFull: Hendriks LEL
      – PersonEntity:
          Name:
            NameFull: van Geel RMJM
      – PersonEntity:
          Name:
            NameFull: van Geffen WH
      – PersonEntity:
          Name:
            NameFull: van den Heuvel M
      – PersonEntity:
          Name:
            NameFull: Oude Munnink TH
      – PersonEntity:
          Name:
            NameFull: Smit EF
      – PersonEntity:
          Name:
            NameFull: Guchelaar HJ
      – PersonEntity:
          Name:
            NameFull: Moes DJAR
      – PersonEntity:
          Name:
            NameFull: Ter Heine R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 23
              M: 05
              Text: 2026 May 23
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1879-0852
          Numbering:
            – Type: volume
              Value: 243
          Titles:
            – TitleFull: European journal of cancer (Oxford, England : 1990)
              Type: main
ResultId 1